You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Boehringer Ingelheim
Mallinckrodt
Express Scripts
AstraZeneca

Last Updated: June 5, 2020

DrugPatentWatch Database Preview

Pharmadax Inc Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for PHARMADAX INC, and what generic and branded alternatives to PHARMADAX INC drugs are available?

PHARMADAX INC has five approved drugs.



Summary for Pharmadax Inc
US Patents:0
Tradenames:4
Ingredients:4
NDAs:5
Patent Litigation for Pharmadax Inc: See patent lawsuits for Pharmadax Inc

Drugs and US Patents for Pharmadax Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmadax Inc METOPROLOL SUCCINATE metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 203028-001 Mar 31, 2020 AB RX No No   Start Trial   Start Trial
Pharmadax Inc QUETIAPINE FUMARATE quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 206260-003 May 9, 2017 AB RX No No   Start Trial   Start Trial
Pharmadax Inc LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 201464-001 May 25, 2012 AB RX No No   Start Trial   Start Trial
Pharmadax Inc METOPROLOL SUCCINATE metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 203699-002 Mar 30, 2020 AB RX No No   Start Trial   Start Trial
Pharmadax Inc QUETIAPINE FUMARATE quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 206260-005 May 9, 2017 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Boehringer Ingelheim
Express Scripts
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.